Literature DB >> 20223993

Hypoxia-induced vasodilation and effects of regional phentolamine in awake patients with sleep apnea.

Raman Moradkhan1, Brett Spitnale, Patrick McQuillan, Cynthia Hogeman, Kristen S Gray, Urs A Leuenberger.   

Abstract

Obstructive sleep apnea (OSA) is associated with increased sympathetic nerve activity, endothelial dysfunction, and premature cardiovascular disease. To determine whether hypoxia is associated with impaired skeletal muscle vasodilation, we compared femoral artery blood flow (ultrasound) and muscle sympathetic nerve activity (peroneal microneurography) during exposure to acute systemic hypoxia (fraction of inspired oxygen 0.1) in awake patients with OSA (n=10) and controls (n=8). To assess the role of elevated sympathetic nerve activity, in a separate group of patients with OSA (n=10) and controls (n=10) we measured brachial artery blood flow during hypoxia before and after regional alpha-adrenergic block with phentolamine. Despite elevated sympathetic activity, in OSA the vascular responses to hypoxia in the leg did not differ significantly from those in controls [P=not significant (NS)]. Following regional phentolamine, in both groups the hypoxia-induced increase in brachial blood flow was markedly enhanced (OSA pre vs. post, 84+/-13 vs. 201+/-34 ml/min, P<0.002; controls pre vs. post 62+/-8 vs. 140+/-26 ml/min, P<0.01). At end hypoxia after phentolamine, the increase of brachial blood flow above baseline was similar (OSA vs. controls +61+/-16 vs. +48+/-6%; P=NS). We conclude that despite high sympathetic vasoconstrictor tone and prominent sympathetic responses to acute hypoxia, hypoxia-induced limb vasodilation is preserved in OSA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223993      PMCID: PMC2867527          DOI: 10.1152/japplphysiol.90855.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  47 in total

1.  Increased vasoconstrictor sensitivity in obstructive sleep apnea.

Authors:  H Kraiczi; J Hedner; Y Peker; J Carlson
Journal:  J Appl Physiol (1985)       Date:  2000-08

2.  Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.

Authors:  Virginia A Imadojemu; Kevin Gleeson; Sadeq A Quraishi; Allen R Kunselman; Lawrence I Sinoway; Urs A Leuenberger
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

3.  Reduced alpha- and beta(2)-adrenergic vascular response in patients with obstructive sleep apnea.

Authors:  L Grote; H Kraiczi; J Hedner
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

4.  Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms.

Authors:  A Barceló; M A Elorza; F Barbé; C Santos; L R Mayoralas; A G Agusti
Journal:  Eur Respir J       Date:  2001-04       Impact factor: 16.671

5.  Effects of regional phentolamine on hypoxic vasodilatation in healthy humans.

Authors:  C J Weisbrod; C T Minson; M J Joyner; J R Halliwill
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

6.  Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure.

Authors:  M S Ip; B Lam; L Y Chan; L Zheng; K W Tsang; P C Fung; W K Lam
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

7.  Effects of forearm bier block with bretylium on the hemodynamic and metabolic responses to handgrip.

Authors:  F Lee; J K Shoemaker; P M McQuillan; A R Kunselman; M B Smith; Q X Yang; H Smith; K Gray; L I Sinoway
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-08       Impact factor: 4.733

8.  Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia.

Authors:  Richard Schulz; Christoph Hummel; Sabine Heinemann; Werner Seeger; Friedrich Grimminger
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

9.  Adenosine contributes to hypoxia-induced forearm vasodilation in humans.

Authors:  U A Leuenberger; K Gray; M D Herr
Journal:  J Appl Physiol (1985)       Date:  1999-12

10.  Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea.

Authors:  M Kato; P Roberts-Thomson; B G Phillips; W G Haynes; M Winnicki; V Accurso; V K Somers
Journal:  Circulation       Date:  2000-11-21       Impact factor: 39.918

View more
  5 in total

1.  Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP.

Authors:  Renaud Tamisier; Can Ozan Tan; Jean-Louis Pepin; Patrick Levy; J Andrew Taylor
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

2.  Effect of obesity and metabolic syndrome on hypoxic vasodilation.

Authors:  Jacqueline K Limberg; Trent D Evans; Gregory M Blain; David F Pegelow; Jessica R Danielson; Marlowe W Eldridge; Lester T Proctor; Joshua J Sebranek; William G Schrage
Journal:  Eur J Appl Physiol       Date:  2011-06-09       Impact factor: 3.078

3.  Vascular Response During Mental Stress in Sedentary and Physically Active Patients With Obstructive Sleep Apnea.

Authors:  Rosyvaldo Ferreira-Silva; Thiago T Goya; Eline R F Barbosa; Bruno G Durante; Carlos E L Araujo; Geraldo Lorenzi-Filho; Linda M Ueno-Pardi
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

4.  Hypoxia selectively upregulates cation channels and increases cytosolic [Ca2+] in pulmonary, but not coronary, arterial smooth muscle cells.

Authors:  Xi He; Shanshan Song; Ramon J Ayon; Angela Balisterieri; Stephen M Black; Ayako Makino; W Gil Wier; Wei-Jin Zang; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-03       Impact factor: 4.249

5.  Ascorbic acid does not enhance hypoxia-induced vasodilation in healthy older men.

Authors:  Jonathan P Pollock; Hardikkumar M Patel; Brittney J Randolph; Matthew J Heffernan; Urs A Leuenberger; Matthew D Muller
Journal:  Physiol Rep       Date:  2014-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.